Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
MSF Science Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib, review by @MSF in Journal of Pharmaceutical Policy and Practice: ow.ly/RrHX50y6GLo @MSF_access 02:01 - 28 Jan 2020